This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wulf GG, Hasenkamp J, Jung W, Chapuy B, Truemper L, Glass B . Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin’s lymphoma. Bone Marrow Transplant 2005; 36: 271–273.
Vaglio A, Palmisano A, Corradi D, Salvarani C, Buzio C . Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin North Am 2007; 33: 803–817, vi–vii.
Scheel PJ, Feeley N . Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation. Medicine 2009; 88: 202–207.
Vaglio A, Salvarani C, Buzio C . Retroperitoneal fibrosis. Lancet 2006; 367: 241–251.
Nanda A, Rizzo JD, Vogelsang GB . A case of retroperitoneal fibrosis in a patient following HSCT. Bone Marrow Transplant 2005; 35: 1125–1126.
Kamisawa T, Okamoto A . IgG4-related sclerosing disease. World J Gastroenterol 2008; 14: 3948–3955.
Cheuk W, Chan JKC . IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 2010; 17: 303–332.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Dicke, C., Kertész, A., Henke, R. et al. Retroperitoneal fibrosis as manifestation of chronic GVHD after allogeneic hematopoietic SCT. Bone Marrow Transplant 48, 467–468 (2013). https://doi.org/10.1038/bmt.2012.165
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2012.165